1-[3-(1,3-dimethylpyrazol-4-yl)-7-fluoroisoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(1,3-dimethylpyrazol-4-yl)isoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;7-methyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one

C103H111F2N23O9 — CID 158072913

IUPAC1-[3-(1,3-dimethylpyrazol-4-yl)-7-fluoroisoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(1,3-dimethylpyrazol-4-yl)isoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;7-methyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one
SMILESCN1Cc2c(-c3c(F)ccc4cc(N5CCOCC5)ncc34)nc(C3CCOCC3)n2CC1=O.Cc1cc2c(-c3nc(C4CCOCC4)n4c3CN(C)C(=O)C4)cccc2nc1-c1cnn(C)c1.Cc1nn(C)cc1-c1cc2ccc(F)c(-c3nc(C4CCOCC4)n4c3CN(C)C(=O)C4)c2cn1.Cc1nn(C)cc1-c1cc2cccc(-c3nc(C4CCOCC4)n4c3CN(C)C(=O)C4)c2cn1
InChIInChI=1S/C26H27FN6O2.2C26H28N6O2.C25H28FN5O3/c1-15-19(12-32(3)30-15)21-10-17-4-5-20(27)24(18(17)11-28-21)25-22-13-31(2)23(34)14-33(22)26(29-25)16-6-8-35-9-7-16;1-16-21(13-31(3)29-16)22-11-18-5-4-6-19(20(18)12-27-22)25-23-14-30(2)24(33)15-32(23)26(28-25)17-7-9-34-10-8-17;1-16-11-20-19(5-4-6-21(20)28-24(16)18-12-27-31(3)13-18)25-22-14-30(2)23(33)15-32(22)26(29-25)17-7-9-34-10-8-17;1-29-14-20-24(28-25(31(20)15-22(29)32)16-4-8-33-9-5-16)23-18-13-27-21(30-6-10-34-11-7-30)12-17(18)2-3-19(23)26/h4-5,10-12,16H,6-9,13-14H2,1-3H3;2*4-6,11-13,17H,7-10,14-15H2,1-3H3;2-3,12-13,16H,4-11,14-15H2,1H3
InChIKeyFMAHLAHYBZIFFF-UHFFFAOYSA-N
MW1853.17 g/mol
LogP14.10
Rot. Bonds12

About 1-[3-(1,3-dimethylpyrazol-4-yl)-7-fluoroisoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(1,3-dimethylpyrazol-4-yl)isoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;7-methyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one

1-[3-(1,3-dimethylpyrazol-4-yl)-7-fluoroisoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(1,3-dimethylpyrazol-4-yl)isoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;7-methyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one (PubChem CID 158072913) has the molecular formula C103H111F2N23O9 and a molecular weight of 1853.17 g/mol. Its IUPAC name is 1-[3-(1,3-dimethylpyrazol-4-yl)-7-fluoroisoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(1,3-dimethylpyrazol-4-yl)isoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;7-methyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one.

Molecular Properties

Compound Name1-[3-(1,3-dimethylpyrazol-4-yl)-7-fluoroisoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(1,3-dimethylpyrazol-4-yl)isoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;7-methyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one
PubChem CID158072913
Molecular FormulaC103H111F2N23O9
Molecular Weight1853.17 g/mol
Exact Mass1851.89
IUPAC Name1-[3-(1,3-dimethylpyrazol-4-yl)-7-fluoroisoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(1,3-dimethylpyrazol-4-yl)isoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;7-methyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one
SMILESCN1Cc2c(-c3c(F)ccc4cc(N5CCOCC5)ncc34)nc(C3CCOCC3)n2CC1=O.Cc1cc2c(-c3nc(C4CCOCC4)n4c3CN(C)C(=O)C4)cccc2nc1-c1cnn(C)c1.Cc1nn(C)cc1-c1cc2ccc(F)c(-c3nc(C4CCOCC4)n4c3CN(C)C(=O)C4)c2cn1.Cc1nn(C)cc1-c1cc2cccc(-c3nc(C4CCOCC4)n4c3CN(C)C(=O)C4)c2cn1
InChIInChI=1S/C26H27FN6O2.2C26H28N6O2.C25H28FN5O3/c1-15-19(12-32(3)30-15)21-10-17-4-5-20(27)24(18(17)11-28-21)25-22-13-31(2)23(34)14-33(22)26(29-25)16-6-8-35-9-7-16;1-16-21(13-31(3)29-16)22-11-18-5-4-6-19(20(18)12-27-22)25-23-14-30(2)24(33)15-32(23)26(28-25)17-7-9-34-10-8-17;1-16-11-20-19(5-4-6-21(20)28-24(16)18-12-27-31(3)13-18)25-22-14-30(2)23(33)15-32(22)26(29-25)17-7-9-34-10-8-17;1-29-14-20-24(28-25(31(20)15-22(29)32)16-4-8-33-9-5-16)23-18-13-27-21(30-6-10-34-11-7-30)12-17(18)2-3-19(23)26/h4-5,10-12,16H,6-9,13-14H2,1-3H3;2*4-6,11-13,17H,7-10,14-15H2,1-3H3;2-3,12-13,16H,4-11,14-15H2,1H3
InChIKeyFMAHLAHYBZIFFF-UHFFFAOYSA-N
XLogP14.10
TPSA306.93 Ų
H-Bond Donors
H-Bond Acceptors28
Rotatable Bonds12
Heavy Atoms137
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001853.17
LogP ≤ 514.10
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1028

Analyze 1-[3-(1,3-dimethylpyrazol-4-yl)-7-fluoroisoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(1,3-dimethylpyrazol-4-yl)isoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;7-methyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

US10899769, Example 89a
CID 139558251
US11058688, Example 123
CID 139543520
US10899769, Example 97
CID 139558275
US10899769, Example 27
CID 139558303
US10899769, Example 64a
CID 139558309
US10899769, Example 95
CID 139558315
US10899769, Example 89b
CID 139558396
US10899769, Example 93
CID 139570784
US10899769, Example 98
CID 139570832
US10899769, Example 26a
CID 139570987
US10899769, Example 26b
CID 139570996
US10899769, Example 36a
CID 139571042

Frequently Asked Questions

What is the IUPAC name of 1-[3-(1,3-dimethylpyrazol-4-yl)-7-fluoroisoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(1,3-dimethylpyrazol-4-yl)isoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;7-methyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one?
The IUPAC name of 1-[3-(1,3-dimethylpyrazol-4-yl)-7-fluoroisoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(1,3-dimethylpyrazol-4-yl)isoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;7-methyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one (CID 158072913) is 1-[3-(1,3-dimethylpyrazol-4-yl)-7-fluoroisoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(1,3-dimethylpyrazol-4-yl)isoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;7-methyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one.
What is the SMILES notation for 1-[3-(1,3-dimethylpyrazol-4-yl)-7-fluoroisoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(1,3-dimethylpyrazol-4-yl)isoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;7-methyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one?
The canonical SMILES for 1-[3-(1,3-dimethylpyrazol-4-yl)-7-fluoroisoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(1,3-dimethylpyrazol-4-yl)isoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;7-methyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one is CN1Cc2c(-c3c(F)ccc4cc(N5CCOCC5)ncc34)nc(C3CCOCC3)n2CC1=O.Cc1cc2c(-c3nc(C4CCOCC4)n4c3CN(C)C(=O)C4)cccc2nc1-c1cnn(C)c1.Cc1nn(C)cc1-c1cc2ccc(F)c(-c3nc(C4CCOCC4)n4c3CN(C)C(=O)C4)c2cn1.Cc1nn(C)cc1-c1cc2cccc(-c3nc(C4CCOCC4)n4c3CN(C)C(=O)C4)c2cn1.
What is the InChIKey of 1-[3-(1,3-dimethylpyrazol-4-yl)-7-fluoroisoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(1,3-dimethylpyrazol-4-yl)isoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;7-methyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one?
The InChIKey is FMAHLAHYBZIFFF-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H27FN6O2.2C26H28N6O2.C25H28FN5O3/c1-15-19(12-32(3)30-15)21-10-17-4-5-20(27)24(18(17)11-28-21)25-22-13-31(2)23(34)14-33(22)26(29-25)16-6-8-35-9-7-16;1-16-21(13-31(3)29-16)22-11-18-5-4-6-19(20(18)12-27-22)25-23-14-30(2)24(33)15-32(23)26(28-25)17-7-9-34-10-8-17;1-16-11-20-19(5-4-6-21(20)28-24(16)18-12-27-31(3)13-18)25-22-14-30(2)23(33)15-32(22)26(29-25)17-7-9-34-10-8-17;1-29-14-20-24(28-25(31(20)15-22(29)32)16-4-8-33-9-5-16)23-18-13-27-21(30-6-10-34-11-7-30)12-17(18)2-3-19(23)26/h4-5,10-12,16H,6-9,13-14H2,1-3H3;2*4-6,11-13,17H,7-10,14-15H2,1-3H3;2-3,12-13,16H,4-11,14-15H2,1H3.
What are the key properties of 1-[3-(1,3-dimethylpyrazol-4-yl)-7-fluoroisoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(1,3-dimethylpyrazol-4-yl)isoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;7-methyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one?
1-[3-(1,3-dimethylpyrazol-4-yl)-7-fluoroisoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(1,3-dimethylpyrazol-4-yl)isoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;7-methyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one has a molecular weight of 1853.17 g/mol, XLogP of 14.10, 12 rotatable bonds, 0 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[3-(1,3-dimethylpyrazol-4-yl)-7-fluoroisoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(1,3-dimethylpyrazol-4-yl)isoquinolin-8-yl]-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-(7-fluoro-3-morpholin-4-ylisoquinolin-8-yl)-7-methyl-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;7-methyl-1-[3-methyl-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-3-(oxan-4-yl)-5,8-dihydroimidazo[1,5-a]pyrazin-6-one is sourced from PubChem (CID 158072913), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).